• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿奇霉素分子结构对药代动力学及抗菌活性的影响

[Effect of the molecular structure of azithromycin on pharmacokinetics and the antimicrobial activity].

作者信息

Pechère J C

机构信息

Département de Génétique et Microbiologie, CMU, Genève, Suisse.

出版信息

Pathol Biol (Paris). 1995 Jun;43(6):483-7.

PMID:8539069
Abstract

Azithromycin possesses in position 9 of the lactone cycle a nitrogen atom which provides a second site of protonation. Hence, and compared to erythromycin, azithromycin is more stable in the gastric environment, enjoys improved digestive absorption and improved digestive toleration, displays much higher intracellular accumulation responsible for prolonged serum and tissue half-lives, which allows simplified therapeutic schedules. It is also postulated that improved activity against Gram negative isolates such as H. influenzae and B. catarrhalis results from the same structural particularities.

摘要

阿奇霉素在内酯环的9位含有一个氮原子,该氮原子提供了第二个质子化位点。因此,与红霉素相比,阿奇霉素在胃环境中更稳定,具有更好的消化吸收和消化耐受性,表现出更高的细胞内蓄积,这导致血清和组织半衰期延长,从而可以简化治疗方案。还据推测,对革兰氏阴性菌如流感嗜血杆菌和卡他莫拉菌的活性提高也源于相同的结构特性。

相似文献

1
[Effect of the molecular structure of azithromycin on pharmacokinetics and the antimicrobial activity].阿奇霉素分子结构对药代动力学及抗菌活性的影响
Pathol Biol (Paris). 1995 Jun;43(6):483-7.
2
[Azithromycin: tissue pharmacology].[阿奇霉素:组织药理学]
Pathol Biol (Paris). 1995 Jun;43(6):498-504.
3
[Azithromycin: critical points].[阿奇霉素:关键点]
Pathol Biol (Paris). 1995 Jun;43(6):488-97.
4
Inhibition of 50S ribosomal subunit assembly in Haemophilus influenzae cells by azithromycin and erythromycin.阿奇霉素和红霉素对流感嗜血杆菌细胞中50S核糖体亚基组装的抑制作用。
Curr Microbiol. 2002 Jun;44(6):418-24. doi: 10.1007/s00284-001-0016-6.
5
[In vitro and in vivo antibacterial activities of azithromycin].阿奇霉素的体外和体内抗菌活性
Jpn J Antibiot. 2000 Jun;53 Suppl B:22-42.
6
Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam.
Arzneimittelforschung. 1996 Feb;46(2):213-7.
7
Review of azithromycin activity against Legionella spp.阿奇霉素对军团菌属活性的综述
Pathol Biol (Paris). 1995 Jun;43(6):569-72.
8
Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.在临床前感染模型中,单剂量阿奇霉素方案与多剂量阿奇霉素方案相比疗效增强。
J Antimicrob Chemother. 2005 Aug;56(2):365-71. doi: 10.1093/jac/dki241. Epub 2005 Jul 7.
9
The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.阿奇霉素在杀菌动力学模型中的药效学特性及其对细菌性结膜炎治疗的意义。
Adv Ther. 2008 Mar;25(3):208-17. doi: 10.1007/s12325-008-0034-x.
10
A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.一种针对血清和上皮衬液中抗体内选择的肺炎链球菌突变体的抗菌活性的药效学方法及其与肺炎临床治疗失败的关联。
J Antimicrob Chemother. 2006 Aug;58(2):349-58. doi: 10.1093/jac/dkl250. Epub 2006 Jun 16.

引用本文的文献

1
Azithromycin in the Management of Upper Respiratory Tract Infections (URTIs): Indian Real-Life Experience.阿奇霉素在上呼吸道感染(URTIs)治疗中的应用:印度真实病例经验
Infect Drug Resist. 2025 Jan 27;18:523-531. doi: 10.2147/IDR.S488479. eCollection 2025.
2
Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study.睑板腺功能障碍的局部阿奇霉素和口服多西环素治疗:一项临床和光谱学的初步比较研究。
Cornea. 2013 Jan;32(1):44-53. doi: 10.1097/ICO.0b013e318254205f.
3
Azithromycin in DuraSite for the treatment of blepharitis.
用于治疗睑缘炎的DuraSite中的阿奇霉素。
Clin Ophthalmol. 2010 Jul 30;4:681-8. doi: 10.2147/opth.s6370.